|
|
|
Volumn 7, Issue 11 SUPPL., 2001, Pages
|
|
The pharmacoeconomics of venlafaxine in depression
a
a
NONE
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMITRIPTYLINE;
DESIPRAMINE;
FLUOXETINE;
FLUVOXAMINE;
IMIPRAMINE;
NORADRENALIN UPTAKE INHIBITOR;
NORTRIPTYLINE;
PAROXETINE;
PLACEBO;
SEROTONIN UPTAKE INHIBITOR;
SERTRALINE;
TRICYCLIC ANTIDEPRESSANT AGENT;
VENLAFAXINE;
ANXIETY;
CLINICAL PRACTICE;
CLINICAL TRIAL;
COMORBIDITY;
COMPARATIVE STUDY;
COST BENEFIT ANALYSIS;
COST CONTROL;
COST EFFECTIVENESS ANALYSIS;
DELAYED RELEASE FORMULATION;
DEPRESSION;
DOSE CALCULATION;
DRUG COST;
DRUG EFFICACY;
DRUG FORMULARY;
DRUG RESPONSE;
ECONOMIC EVALUATION;
HEALTH CARE COST;
HEALTH CARE UTILIZATION;
HEALTH INSURANCE;
HEALTH MAINTENANCE ORGANIZATION;
HEALTH SERVICE;
HOSPITAL CARE;
HUMAN;
MANAGED CARE ORGANIZATION;
MEDICAL DECISION MAKING;
META ANALYSIS;
OUTPATIENT CARE;
PHYSICIAN;
PREVALENCE;
PRIORITY JOURNAL;
PUBLIC HEALTH;
RELAPSE;
REMISSION;
REVIEW;
SIDE EFFECT;
UNITED STATES;
ANTIDEPRESSIVE AGENTS, SECOND-GENERATION;
ANTIDEPRESSIVE AGENTS, TRICYCLIC;
ANXIETY;
COST-BENEFIT ANALYSIS;
CYCLOHEXANOLS;
DEPRESSION;
DRUG UTILIZATION REVIEW;
HUMANS;
MANAGED CARE PROGRAMS;
SEROTONIN UPTAKE INHIBITORS;
UNITED STATES;
|
|
EID: 0034799476
PISSN: 10880224
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (10)
|
|
References (19)
|
